Gritstone bio, Inc. - Common Stock (GRTS)
0.0322
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 2nd, 7:29 PM EDT

Via Benzinga · October 21, 2024

Via Benzinga · October 21, 2024

Via Benzinga · October 17, 2024

Via Benzinga · October 15, 2024

Gritstone bio shares are trading lower by 65% during Thursday's session. The company announced it voluntarily filed for Chapter 11 restructuring.
Via Benzinga · October 10, 2024

Via Benzinga · October 15, 2024

Via Benzinga · October 15, 2024

Via Benzinga · October 14, 2024

Via Benzinga · October 14, 2024

Via Benzinga · June 14, 2024

Via Benzinga · October 11, 2024

Via Benzinga · October 10, 2024

Via Benzinga · October 10, 2024

Via Benzinga · October 10, 2024

Via Benzinga · October 10, 2024

Via Benzinga · October 1, 2024

Gritstone Bio's Phase 2 data for GRANITE in MSS-CRC shows promising results, including a 38% risk reduction for patients with low ctDNA. Gritstone plans to review the data with the FDA for potential next steps.
Via Benzinga · October 1, 2024

Via Benzinga · October 1, 2024

Via Benzinga · October 1, 2024

GRTS stock results show that Gritstone Bio beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 13, 2024